| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/22/2005 | US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869933 Peptides having an amino acid sequences of the partial region of the protein from human immunodeficiency virus; cytotoxic t-cells (ctl) |
| 03/22/2005 | US6869608 Peptides derived from a retrovirus of the HIV group and their use |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | CA2467249C Polyene polyketides, processes for their production and their use as pharmaceuticals |
| 03/22/2005 | CA2142638C Antibiotic wap-8294a, method for preparing the same and antibacterial composition |
| 03/22/2005 | CA2135630C Hiv protein epitopes immunologically homologous to hla |
| 03/22/2005 | CA2134761C Synthetic peptide vaccines for dental caries |
| 03/22/2005 | CA2127541C Recombinant swinepox virus |
| 03/22/2005 | CA2125189C Pyropheophorbides and their use in photodynamic therapy |
| 03/17/2005 | WO2005024031A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof |
| 03/17/2005 | WO2005023819A1 Thienopyrroles as antiviral agents |
| 03/17/2005 | WO2005023805A1 Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate |
| 03/17/2005 | WO2005023788A1 Fki-1366 substances and process for producing the same |
| 03/17/2005 | WO2005023771A1 Chemokine receptor antagonist and medical use thereof |
| 03/17/2005 | WO2005023368A1 Prophylaxis of and treatment for infections from the family chlamydiaceae using amino acids as leucine or methionine |
| 03/17/2005 | WO2005023308A1 Formulations of vitamin k-dependent polypeptides and sulfoalkyl ether cycloextrins |
| 03/17/2005 | WO2005023290A2 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections |
| 03/17/2005 | WO2005023289A1 Medicinal composition for treating chronic hepatitis c |
| 03/17/2005 | WO2005023277A1 A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion |
| 03/17/2005 | WO2005023275A1 Pharmaceutical active ingredient against hepatitis |
| 03/17/2005 | WO2005023270A2 Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
| 03/17/2005 | WO2005023263A1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 03/17/2005 | WO2005023259A1 Itraconazole solution |
| 03/17/2005 | WO2005023245A1 Novel cycloalkyl’b! condensed indoles |
| 03/17/2005 | WO2005023240A2 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 03/17/2005 | WO2005023184A2 Antibiotic product, use and formulation thereof |
| 03/17/2005 | WO2005011649A3 Methods of treating severe acute respiratory syndrome virus infections |
| 03/17/2005 | WO2005007669A8 Novel fusidic acid derivatives |
| 03/17/2005 | WO2005004911B1 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 03/17/2005 | WO2005003087A3 Oxazole derivatives as antibacterial agents |
| 03/17/2005 | WO2004110441A8 Pharmaceutical formulations comprising amoxicillin and clavulanate |
| 03/17/2005 | WO2004105779A3 Green tea and oplyphenol inhibitors of bacterial proteases |
| 03/17/2005 | WO2004103408A3 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 03/17/2005 | WO2004082669A3 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders |
| 03/17/2005 | WO2004076619A3 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | WO2004022729A8 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/17/2005 | WO2003101484A9 Compositions and methods for transepithelial molecular transport |
| 03/17/2005 | WO2003053959A8 Heterocyclylamino carbonyluracils |
| 03/17/2005 | WO2003011898A3 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 03/17/2005 | WO2002074156A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050060770 Antifungal proteins |
| 03/17/2005 | US20050059815 Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom |
| 03/17/2005 | US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester |
| 03/17/2005 | US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059677 Pyralopyridines, process for their preparation and use as therapeutic compounds |
| 03/17/2005 | US20050059674 reducing granulation tissue in humans having otitis and an open tympanic membrane comprising topically applying an aqueous suspension composition containing a combination of ciprofloxacin and dexamethasone |
| 03/17/2005 | US20050059670 Isethionate salt of a selective CKD4 inhibitor |
| 03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059658 N-(2,4-Difluorophenyl)-N'-[3-(4,4-dimethyl-6-oxo-1,4,5,6-tetrahydro-3-pyridazinyl)-phenyl]urea and intermediates; antiviral |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059642 Plant fungicides and bactericides; antibiotic resistant staphylococcus and enterococcus; turf grasses; improved chemical resistance and stability |
| 03/17/2005 | US20050059626 Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059617 Novel anitsense oligonucleotide derivatives against to hepatitis c virus |
| 03/17/2005 | US20050059606 hexapeptides including enantiomers, stereoisomers and tautomers, used as enzyme inhibitors for prophylaxis or prevention of viral diseases |
| 03/17/2005 | US20050059587 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy |
| 03/17/2005 | US20050058982 Modified small interfering RNA molecules and methods of use |
| 03/17/2005 | US20050058731 Treatment for cuticles or skin tissue; may also comprise avocado oil, primrose oil, juniper oil, grapefruit oil, chamomile oil, lavender oil with an effective amount of triclosan antifungal/antimicrobial agent |
| 03/17/2005 | US20050058667 Adjuvants for use in vaccines |
| 03/17/2005 | US20050058660 Novel surface antigen |
| 03/17/2005 | US20050058659 Forming fusion peptides with 14 to 75 amino acids in prokaryotic host cell and encoding fusion peptide for expression vectors |
| 03/17/2005 | US20050058657 Vaccines for treatment of Aids |
| 03/17/2005 | US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases |
| 03/17/2005 | DE10337993A1 Aminobenzimidazole Aminobenzimidazoles |
| 03/17/2005 | DE10337761A1 Phosphororganische 4-Iminohydantoinderivate Organophosphorus 4-Iminohydantoinderivate |
| 03/17/2005 | DE10337191A1 Neue Verwendung von Chinolon-Antibiotika New use of quinolone antibiotics |
| 03/17/2005 | DE10335061A1 Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten Process for preparing OH-protected [4- (2,6-Damino-9H-purin-9-yl) -1,3-dioxolan-2-yl] methanol derivatives |
| 03/17/2005 | CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents |
| 03/17/2005 | CA2537995A1 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 03/17/2005 | CA2537878A1 Polymorphic nucleoside compounds |
| 03/17/2005 | CA2537677A1 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 03/17/2005 | CA2537545A1 Thienopyrroles as antiviral agents |
| 03/17/2005 | CA2537281A1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 03/17/2005 | CA2537145A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof |
| 03/17/2005 | CA2535780A1 Antibiotic product, use and formulation thereof |
| 03/17/2005 | CA2526428A1 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections |
| 03/16/2005 | EP1514937A1 Production of vaccines |
| 03/16/2005 | EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 03/16/2005 | EP1514555A1 Polyherbal formulation for hepatic and splenic disorders |
| 03/16/2005 | EP1514552A1 Novel fused imidazole derivative |
| 03/16/2005 | EP1513959A2 Antiviral inhibitions of capsid proteins |
| 03/16/2005 | EP1513924A1 Attenuated listeria spp. and methods for using the same |
| 03/16/2005 | EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513856A1 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |